We are leading a confidential executive search for a Chief Financial Officer on behalf of a high-growth international portfolio company with revenues approaching $200m. The business operates with global R&D, multi-site manufacturing, and commercialisation across Asia, Europe, and the U.S.
As part of the executive leadership team, the CFO will:
- Lead and strengthen global finance operations, including planning, controlling, and treasury.
- Partner closely with the CEO and board to support commercial growth and long-term strategy.
- Guide a finance and digital team of 6–7.
- Play a central role in M&A, partnerships, alliances, and preparing the business for future capital markets activity (HK/Europe IPO exposure is highly valued).
Candidate Profile
- A Chinese national with a proven record leading finance in global organisations.
- Experience bridging large corporates and mid-sized growth companies.
- Strong exposure to international capital markets and IPO processes.
- MedTech, pharma, or related life sciences background desirable, but strategic thinking and cross-cultural leadership are paramount.
Compensation: Highly competitive, with equity participation via a stock option plan in development.
Timeline: Target onboarding by January 2026.
Due to the confidential nature of this appointment, further details will only be shared with shortlisted candidates under NDA.
